Search
David Solit, MD, Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, is the featured speaker for the June 3 episode of “MSK Science Spotlight.”
Learn about the questions to ask a lung cancer doctor after being diagnosed, from an MSK specialist who has successfully treated many people for lung cancer.
Conozca las preguntas que debe hacerle a un médico especialista en cáncer pulmonar después de recibir el diagnóstico, de la mano de un especialista de MSK que ha tratado con éxito a muchas personas con cáncer pulmonar.
Memorial Sloan Kettering Cancer Center (MSK) is proud to announce that Larry Norton, MD, has been elected to the American Academy of the Arts & Sciences, and Michel Sadelain, MD, PhD, has been named the recipient of the Outstanding Achievement Award from the American Society of Gene and Cell Therapy.
Investigators have shown how gut microbes promote the formation of a type of immune cell called regulatory T cells.
Learn how new clinical trials at MSK are helping make cancer care at home a reality.
Meet Andrew Kung, MSK’s new Chair of the Department of Pediatrics.
The surgical removal of the ovaries has been widely adopted as a cancer-risk-reducing strategy for women with either BRCA1 or BRCA2 mutations. A new multicenter study led by researchers at Memorial Sloan Kettering Cancer Center is the first prospective examination of the impact of this procedure in which BRCA2 mutation carriers were analyzed separately from BRCA1 mutation carriers.
Memorial Sloan Kettering Cancer Center (MSK) today announced the largest single donation in its nearly 150-year history, a $400 million gift from Kenneth C. Griffin, Founder and Chief Executive Officer of Citadel and Founder of Griffin Catalyst, and David Geffen, Founder of The David Geffen Foundation. It will serve as the cornerstone of MSK’s foundation for the future and will be instrumental in extending the power and potential of cancer care and treatment to people across New York and around the world as MSK continues to advance cutting-edge research and new cancer treatments.
Given the current pandemic, every time a healthcare provider asks a patient to come in for an appointment, they’re making a mental calculation of the risk and benefit. Utilizing telemedicine has allowed providers at Memorial Sloan Kettering (MSK) to keep patients safely sheltered at home, while continuing to provide their necessary care.